Compare IPHA & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPHA | FRD |
|---|---|---|
| Founded | 1999 | 1965 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 324.2M |
| IPO Year | 2014 | 1995 |
| Metric | IPHA | FRD |
|---|---|---|
| Price | $2.23 | $43.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | ★ 172.7K | 83.9K |
| Earning Date | 03-26-2026 | 06-11-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.79 |
| Revenue | N/A | ★ $121,157,278.00 |
| Revenue This Year | $180.36 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $23.49 |
| Revenue Growth | N/A | ★ 55.82 |
| 52 Week Low | $1.18 | $16.55 |
| 52 Week High | $2.71 | $48.77 |
| Indicator | IPHA | FRD |
|---|---|---|
| Relative Strength Index (RSI) | 57.37 | 56.68 |
| Support Level | $1.68 | $17.68 |
| Resistance Level | $2.66 | $48.77 |
| Average True Range (ATR) | 0.15 | 2.73 |
| MACD | 0.01 | -0.39 |
| Stochastic Oscillator | 54.50 | 45.25 |
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
Friedman Industries Inc is a manufacturer and processor of metals and operates in two reportable segments: flat-roll products and tubular products. The flat-roll product segment consists of flat-roll processing facilities located in Hickman, Arkansas; Decatur, Alabama; Miami, Florida; East Chicago, Indiana; Granite City, Illinois and Sinton, Texas and a flat-roll distribution facility located in Orlando, Florida. The tubular product segment consists of the Company's Texas Tubular Products division (TTP) located in Lone Star, Texas. TTP operates two electric resistance welded pipe mills with a combined outside diameter (OD). Its products are flat-roll products and tubular products.